SCHEMBL19166121

SCHEMBL19166121

c1ccc(-c2cc(-c3ccc(-c4ccc5oc6ccccc6c5c4)cc3)nc(-c3cccc(-c4ccncc4)c3)n2)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PLA2G2A P14555 3/20 0.43
▸ PLA2G4A P47712 3/20 0.43
▸ DHODH Q02127 1/20 0.43
▸ PLA2G10 O15496 1/20 0.43
▸ MAPT P10636 8/20 0.41
▸ ALDH1A1 P00352 6/20 0.41
▸ KDM4E B2RXH2 6/20 0.41
▸ MEN1 O00255 5/20 0.41
▸ KMT2A Q03164 5/20 0.41
▸ HPGD P15428 5/20 0.41
▸ LMNA P02545 3/20 0.41
▸ DYRK1A Q13627 1/20 0.41
▸ MKNK1 Q9BUB5 1/20 0.41
▸ NTSR1 P30989 1/20 0.40
▸ PIK3CA P42336 1/20 0.40
▸ NPC1 O15118 1/20 0.40
▸ NFKB1 P19838 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ NFKB2 Q00653 1/20 0.40
▸ RELA Q04206 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19166683 0.99 MAPT (0.43) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19165329 0.97 MKNK1 (0.42) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19166005 0.96 MAPT (0.42) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19165806 0.96 DHODH (0.42) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19166682 0.96 MAPT (0.44) PLA2G2APLA2G4ADHODHMAPTALDH1A1
SCHEMBL19166526 0.95 MKNK1 (0.42) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19486918 0.95 MKNK1 (0.42) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19165759 0.95 MKNK1 (0.42) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19166063 0.94 MKNK1 (0.41) PLA2G2APLA2G4ADHODHPLA2G10MAPT
SCHEMBL19166124 0.94 MAPT (0.44) PLA2G2APLA2G4ADHODHMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2017-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170213983-A1 COMPOUND, ORGANIC ELECTROLUMINESCENCE ELEMENT MATERIAL, ORGANIC ELECTROLUMINESCENCE ELEMENT AND ELECTRONIC DEVICE L1CAM, SOD1, OR10J3 PLA2G2A 3552/4885PLA2G4A 4204/4885DHODH 4336/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback